# Pilot Study Evaluating The Efficacy Of Etanercept In Acute Gout

> **NCT03636373** · PHASE4 · TERMINATED · sponsor: **Rutgers, The State University of New Jersey** · enrollment: 5 (actual)

## Conditions studied

- Gout Attack

## Interventions

- **DRUG:** Etanercept
- **DRUG:** Triamcinolone Acetonide

## Key facts

- **NCT ID:** NCT03636373
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-10-25
- **Primary completion:** 2021-08-13
- **Final completion:** 2021-08-13
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** The Sponsor has decided to stop funding this study due to lack of enrollment during COVID-19 pandemic and decreased interest in funding investigator initiated studies pertaining to the study drug
- **Last updated:** 2023-10-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03636373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03636373, "Pilot Study Evaluating The Efficacy Of Etanercept In Acute Gout". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03636373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*